1998
DOI: 10.1093/glycob/8.4.321
|View full text |Cite
|
Sign up to set email alerts
|

Acceptor specificity of the human leukocyte  3 fucosyltransferase: role of FucT-VII in the generation of selectin ligands

Abstract: The alpha3 fucosyltransferase, FucT-VII, is one of the key glycosyltransferases involved in the biosynthesis of the sialyl Lewis X (sLex) antigen on human leukocytes. The sialyl Lewis X antigen (NeuAcalpha(2-3)Galbeta(1-4)[Fucalpha(1-3)]GlcNAc-R) is an essential component of the recruitment of leukocytes to sites of inflammation, mediating the primary interaction between circulating leukocytes and activated endothelium. In order to characterize the enzymatic properties of the leukocyte alpha3 fucosyltransferas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

6
23
0

Year Published

1998
1998
2013
2013

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 40 publications
(29 citation statements)
references
References 33 publications
6
23
0
Order By: Relevance
“…5. The down-regulation of sLe X upon silencing FUT7 is consistent with enzymatic studies (25,33) and cellbased assays (34 -36) that demonstrate a preference for FUT7 to fucosylate terminal and sialylated N-acetyllactosamine (NeuAc␣2,3Gal␤1,4GlcNAc) to generate sLe X -type structures (25,33). Unlike FUT7, however, which has a distinct substrate specificity, FUT4 and FUT9 have overlapping function because they can both form Le X and VIM-2 structures (26,27,29,30,37).…”
Section: Cellsupporting
confidence: 75%
“…5. The down-regulation of sLe X upon silencing FUT7 is consistent with enzymatic studies (25,33) and cellbased assays (34 -36) that demonstrate a preference for FUT7 to fucosylate terminal and sialylated N-acetyllactosamine (NeuAc␣2,3Gal␤1,4GlcNAc) to generate sLe X -type structures (25,33). Unlike FUT7, however, which has a distinct substrate specificity, FUT4 and FUT9 have overlapping function because they can both form Le X and VIM-2 structures (26,27,29,30,37).…”
Section: Cellsupporting
confidence: 75%
“…The synthesis of GSPs with core 2-based O-glycans containing polyfucosylated, polylactosamine sequences may help to address these possibilities. In vitro, FucT-VII can generate a terminal sLe x moiety on a polylactosamine sequence, but cannot add internal fucosyl residues to generate the polyfucosylated, polylactosamine sequence found in the O-glycans of PSGL-1 (50,51). Human and murine leukocytes contain a second ␣1,3-fucosyltransferase, termed FucT-IV, that adds fucosyl residues to internal sequences of polylactosamine (50).…”
Section: Gsp-6 Is a Potent Inhibitor Of Neutrophil Adhesion To Immobimentioning
confidence: 99%
“…Whereas synthetic glycosulfopeptides containing the simple monosialylated monofucosylated C2-O-sLe x bind to P-selectin, the role of sialylated PFPL O-glycans in binding to P-selectin has not been studied. Efficient generation of sialylated PFPL in vitro requires the participation of two human ␣1,3-fucosyltransferases expressed in leukocytes, FucT-IV and FucT-VII (14,15). FucT-IV appears to preferentially fucosylate internal GlcNAc residues within the polylactosamine backbone, whereas FucT-VII fucosylates a GlcNAc residue of the nonreducing sialylated N-acetyllactosamine unit to generate the sLe x terminus (14).…”
mentioning
confidence: 99%